Evgen Pharma recruits over 100 patients into COVID-19 trial
Study is investigating company’s lead asset SFX-01
Read More
Tag: ARDS
Immune Regulation teams with DynPort on COVID-19 drug
The companies will jointly evaluate the potential of ILR201104 to treat COVID-19 related Acute Respiratory Distress Syndrome (ARDS)
Read More
Evgen’s SFX-01 selected for COVID-19 trial
The company is participating in LifeArc’s funding initiative for COVID-19 clinical trials
Read More
Exvastat wins 3.6m euro grant for COVID-19 trial
The firm will work with Vrije Universitat to produce a reformulated version of imatinib and test it in COVID-19 patients
Read More
Faron stock falls on traumakine failure
Shares Finnish group Faron Pharmaceuticals were trading down more than 80 percent on the London Stock Exchange after its key drug traumakine failed in acute respiratory distress syndrome (ARDS).
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
